For example, in breast cancer cells TS inhibits activation of ERK1/2 [31], whereas in MM cells TS activates ERK1/2, and activation is sensitive to the antioxidant NAC (Fig. 3C). This evidence concerns the gene MAPK3 and breast cancer.